The Claim
In 19 adults with elevated cardiometabolic risk, a single acute dose of 5g TOTUM-63 was followed by a statistically significant reduction in postprandial glucose peak (p=0.03) and GIP AUC (p=0.01), suggesting a potential association between this supplement and acute modulation of post-meal glucose and incretin responses.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A single 5g dose of TOTUM-63 reduced the peak blood glucose level and the total exposure to the hormone GIP after a meal in 19 adults with elevated cardiometabolic risk.
See the scientific wording
In 19 adults with elevated cardiometabolic risk, a single acute dose of 5g TOTUM-63 was followed by a statistically significant reduction in postprandial glucose peak (p=0.03) and GIP AUC (p=0.01), suggesting a potential association between this supplement and acute modulation of post-meal glucose and incretin responses.
Plant compounds in the supplement feed beneficial gut bacteria, which produce substances that strengthen the gut lining. This reduces inflammation and changes how gut cells release hormones, leading to less GIP being released after eating, which in turn lowers the spike in blood sugar.
What the research says
1 studyWhen 19 people at risk for diabetes took one dose of this plant-based supplement, their blood sugar spike after eating went down, and a hormone called GIP that helps release insulin also dropped—exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.